Effect of nigella sativa oil extract on lipid profiles in type 2 diabetic patients: A randomized, double blind, placebo-controlled clinical trial

Iranian Journal of Endocrinology and Metabolism

Volumn 16, Issue 6, 2015, Pages 411-418

  Hadi, S ^a   Mirmiran, P ^b   Hosseinpour Niazi, S ^b   Hedayati, M ^c   Azizi, F ^b  

^a National Nutrition and Food Technology Research Institute Tehran   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c IRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Lipid profile; Nigella sativa; Timokinon; Type 2 diabetes

Indexed keywords

ESSENTIAL OIL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NIGELLA SATIVA OIL; PLACEBO; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RANDOMIZED CONTROLLED TRIAL;

EID: 84924660372     PISSN: 16834844     EISSN: 16835476     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sankaranarayanan C, Pari L. Thymoquinone ameliorates chemical induced oxidative stress and =-cell damage in experimental hyperglycemic rats. Chem Biol Interact 2011; 190: 148-54.
2. Bahadoran Z, Mirmiran P, Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 2013; 12: 43.
3. Bahadoran Z, Golzarand M, Mirmiran P, Shiva N, Azizi F. Dietary total antioxidant capacity and the occurrence of metabolic syndrome and its components after a 3-year follow-up in adults: Tehran Lipid and Glucose Study. Nutr Metab (Lond) 2012; 9: 70.
4. Schleicher P, Saleh M. Black seed cumin: the magical Egyptian herb for allergies, asthma, and immune dis orders. Rochester, Vermont: Healing Arts Press. 1998; 90.
5. Gilani A-uH, Jabeen Q, Khan MAU. A review of me dicinal uses and pharmacological activities of Nigella sativa. Pak J Biol Sci 2004; 7: 441-51.
6. Bhatti IU, Rehman FU, Khan M, Marwat S. Effect of prophetic medicine kalonji (Nigella sativa L.) on lipid profile of human beings. An in vivo approach. World Appl Sci J 2009; 6: 1053-7.
7. Ismail M, Al-Naqeep G, Chan KW. Nigella sativa thymoquinone-rich fraction greatly improves plasma antioxidant capacity and expression of antioxidant genes in hypercholesterolemic rats. Free Radic Biol Med 2010; 48: 664-72.
8. Kaleem M, Kirmani D, Asif M, Ahmed Q, Bano B. Biochemical effects of Nigella sativa L seeds in diabetic rats. Indian J Exp Biol 2006; 44: 745-8.
9. el-Dakhakhny M, Mady NI, Halim MA., Nigella sativa L. oil protects against induced hepatotoxicity and impr oves serum lipid profile in rats. Arzneimittelforschung 2000; 50: 832-6.
10. Shah AS, Khan GM, Badshah A, Shah SU, Shah KU, Mirza SA. Nigella sativa provides protection against metabolic syndrome. African Journal of Biotechnology 2012; 11: 10919-25.
11. Gheita TA, Kenawy SA. Effectiveness of Nigella sativa oil in the management of rheumatoid arthritis patients: a placebo controlled study. Phytother Res 2012; 26: 1246-8.
12. Pourghassem-Gargari B, Ebrahimzadeh-Attary V, Rafraf M, Gorbani A. Effect of dietary supplementation with Nigella sativa L. on serum lipid profile, lipid peroxidation and antioxidant defense system in hyperlipidemic rabbits. Journal of Medicinal Plants Research 2009; 3: 815-21.
13. Fararh KM, Ibrahim AK, Elsonosy YA. Thymoquinone enhances the activities of enzymes related to energy metabolism in peripheral leukocytes of diabetic rats. Res Vet Sci 2010; 88: 400-4.
14. Kaatabi H, Bamosa AO, Lebda FM, Al Elq AH, Al-Sultan AI. Favorable impact of Nigella sativa seeds on lipid profile in type 2 diabetic patients. J Family Community Med 2012; 19: 155-61.
15. Najmi A, Nasiruddin M, Khan RA, Haque SF. Effect of Nigella sativa oil on various clinical and biochemical parameters of insulin resistance syndrome. Int J Diabetes Dev ctries 2008; 28: 11.
16. Ibrahim RM, Hamdan NS, Ismail M, Saini SM, Abd Rashid SN, Abd Latiff L, et al. Protective Effects of Nigella sativa on Metabolic Syndrome in Menopausal Women. Adv Pharm Bull 2014; 4: 29.
17. Ibrahim RM, Hamdan NS, Mahmud R, Imam MU, Saini SM, Rashid SN, et al. A randomised controlled trial on hypolipidemic effects of Nigella Sativa seeds powder in menopausal women. J Transl Med 2014; 12: 82.
18. Al-Naqeep G, Ismail M, Yazan LS. Effects of thymoquinone rich fraction and thymoquinone on plasma lipoprotein levels and hepatic low density lipoprotein receptor and 3-hydroxy-3-methylglutaryl coenzyme A reductase genes expression. Journal of Functional Foods 2009; 1: 298-303.
19. Benhaddou-Andaloussi A, Martineau L, Vuong T, Meddah B, Madiraju P, Settaf A, et al. The in vivo antidiabetic activity of Nigella sativa is mediated through activation of the AMPK pathway and increased muscle Glut4 content. Evid Based Complement Alternat Med 2011; 1741-427.
20. Talati R, Baker WL, Pabilonia MS, White CM, Coleman CI. The effects of barley-derived soluble fiber on serum lipids. The Annals of Family Medicine 2009; 7: 157-63.
21. Fararh K, Atoji Y, Shimizu Y, Shiina T, Nikami H, Takewaki T. Mechanisms of the hypoglycaemic and immunopotentiating effects of "Nigella sativa" L. oil in streptozotocin-induced diabetic hamsters. Res Vet Sci 2004; 77: 123-9.
22. Fararh K, Shimizu Y, Shiina T, Nikami H, Ghanem M, Takewaki T. Thymoquinone reduces hepatic glucose production in diabetic hamsters. Res Vet Sci 2005; 79: 219-23.
23. Pari L, Sankaranarayanan C. Beneficial effects of thymoquinone on hepatic key enzymes in streptozotocin-nicotinamide induced diabetic rats. Life Sci 2009; 85: 830-4.
24. Kalantari S, Naghipour M. Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients. Adv Biomed Res 2014; 3: 168.